Biotech

All Articles

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has paid CSPC Pharmaceutical Team $one hundred million for a preclinical heart disease ...

Zephyrm finds Hong Kong IPO to cash period 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, submitting (PDF) for an...

Frazier Life Sciences gets $630M for small, mid-cap biotechs

.Frazier Everyday life Sciences has actually sourced an even further $630 million for its own fund c...

GigaGen gathers up to $135M BARDA money to hammer botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is actually increase its ow...

GPCR company Septerna files for IPO on stamina of preclinical information

.Septerna is about to discover exactly how a biotech without "any sort of relevant professional reco...

Kurma closes initially $154M loot for greatest biotech fund yet

.International VC company Kurma Partners has revealed its newest biotech fund, with 140 million euro...

Prothena ensures one director while yet another leaves-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and ...

Editas profit Vertex Cas9 licensing liberties for $57M

.Versus the scenery of a Cas9 license fight that rejects to die, Editas Medicine is moneying in a po...

Ultragenyx adjusts gene treatment dosing to dial up effectiveness

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson condition genetics therapy UX70...

Biopharma layoff rate supports in Q3: Fierce Biotech review

.As summertime heat turns to cool winds, wishes that this year would deliver widespread business rel...